Treatment of Irregular Sleep-Wake Rhythm Disorder (ISWD)

General Treatment Approach for ISWD

The primary goal of ISWD treatment is to consolidate the sleep-wake cycle by enhancing exposure to environmental time cues ("zeitgebers") 1
ISWD is characterized by lack of a clearly identifiable circadian pattern, with sleep broken into at least 3 different periods throughout the 24-hour day 1
Most commonly encountered in patients with dementia (particularly institutionalized), traumatic brain injury, and mental retardation 1

Light therapy helps consolidate nighttime sleep, decrease agitated behavior, and increase the amplitude of circadian rhythms 1, 2
The American Academy of Sleep Medicine suggests treating ISWD in elderly patients with dementia with light therapy (weak recommendation) 3, 4
Recommended protocol: Bright light exposure 2,500-5,000 lux for 1-2 hours in the morning (09:00-11:00), positioned approximately 1 meter from the patient 5
Duration of treatment typically ranges from 4-10 weeks 5
Morning bright light therapy has been found to decrease daytime napping and increase nighttime sleep in patients with dementia 1, 6

Structured physical and social activity during daytime hours to provide temporal cues 1, 2, 6
Reduce time in bed during the day to minimize daytime napping 2, 6
Create a sleep-conducive environment by reducing nighttime light and noise 2, 6
Improve incontinence care to minimize nighttime awakenings in nursing home residents 2, 6
Establish a structured bedtime routine and encourage at least 30 minutes of daily sunlight exposure 6

The American Academy of Sleep Medicine suggests strategically timed melatonin (weak recommendation) for children/adolescents with neurologic disorders 3, 4
The American Academy of Sleep Medicine suggests avoiding melatonin (weak recommendation against) for elderly with dementia 3, 4, 6
The American Academy of Sleep Medicine strongly recommends against using sleep-promoting medications in elderly patients with dementia with ISWD 3, 4, 5, 6
Hypnotics increase risks of falls and other adverse outcomes in elderly patients with dementia 5, 6
Benzodiazepines should be strictly avoided due to high risk of falls, confusion, and worsening cognitive impairment 6

The American Academy of Sleep Medicine suggests avoiding combined treatments of light therapy with melatonin in elderly patients with dementia (weak recommendation against) 3, 4

Use actigraphy or sleep logs to monitor treatment effectiveness when possible 1
Assess for potential side effects of light therapy, which may include eye irritation, agitation, or confusion in patients with dementia 5

Light therapy may be labor-intensive depending on the method and setting of delivery 5
Modest improvements in outcomes may not justify associated costs in some settings 5
Always assess for potential contraindications to light therapy, including preexisting mania, retinal photosensitivity, and migraine 1
Despite limited high-quality evidence, clinical experience suggests most well-informed patients/caregivers would choose light therapy over no intervention 5